Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products
**Background:** The prioritization of public funds in an equitable and ethically sound manner along with efficient budget allocation are key challenges for governments and budget holders. Following the introduction of generics/biosimilars, the potential total budget made available for reallocation r...
Saved in:
Main Authors: | Samira Toghanian, John Moshtaghi-Svensson, Maria Papageorgiou, Kristin Kittelsen, Christiaan Dolk, Markus Hultstrand, Stina Salomonsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2022.29624 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nutraceuticals and Pharmaceuticals
by: E. A. Poluektova, et al.
Published: (2020-05-01) -
PHARMACEUTICAL GELS
by: Syeda Yamna Zia
Published: (2024-10-01) -
Matemáticas y exclusión
by: Lourdes Rué Rosell
Published: (2008-01-01) -
Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?
by: Anne M. Sydor, et al.
Published: (2024-03-01) -
An Update on African Trypanocide Pharmaceutics and Resistance.
by: Keneth Iceland, Kasozi, et al.
Published: (2023)